InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Monday, 08/22/2022 5:31:06 PM

Monday, August 22, 2022 5:31:06 PM

Post# of 198709
ENZC is a high RISK high REWARD investment.

Will ENZC succeed?

Probably, however it take years for ANY biotech company to bring drugs to the marketplace.

ENZC has laid the foundation, created an A.I .platform , started producing product and is now going through the protocols to commercialization.

ENZC is assisted by multiple scientists with significant experience in the technology relating to production of monoclonal antibodies.

The Company is making continuous progress on its many programs and therapeutics. The Company CEO, Charles Cotropia, said, “We have many collaborative partners with whom we work daily and are focused on expanding that list so that we can achieve, as soon as possible, our many therapeutic goals.”


It hasn't been 2 years since Charles & company restarted what was created many years ago.

Will the stock price ever rise again significantly?

Probably

What we don't know is when and how.

Based on what we do know, once ITV-1 anti-HIV therapeutic is used in Africa and results start to filter out then ENZC will have the catalyst needed to move the stock price.

Why?

First off from a historical view point ITV-1 is already known to work better than anything on the market and less costly.

The original EPIC rise of ENZC was a normal occurrence seen in OTC stocks with possible potential. Also the Covid-19 pandemic and the fact at the time the WHOLE OTC market was on fire, Stocks across the board was making EPIC rises.

This is different now.

ENZC stock appreciation will be based on what is under the hood and does it work.

Africa first then Europe and the rest is history.

How will it flows nobody knows.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News